Humana (NYSE:HUM) Updates FY24 Earnings Guidance

Humana (NYSE:HUM) updated its FY24 earnings guidance on Tuesday. The company provided earnings per share (EPS) guidance of at least $16.00 for the period, compared to the consensus estimate of $16.15.

Analyst Ratings Changes

HUM has been the subject of several analyst reports. Piper Sandler downgraded Humana from an “overweight” rating to a “neutral” rating and reduced their target price for the company from $392.00 to $274.00 in a report on Thursday, October 3rd. Cantor Fitzgerald reissued a “neutral” rating and set a $395.00 price target on shares of Humana in a research report on Tuesday, October 1st. KeyCorp started coverage on shares of Humana in a report on Friday, October 11th. They set a “sector weight” rating on the stock. UBS Group reduced their price objective on shares of Humana from $380.00 to $250.00 and set a “neutral” rating for the company in a research report on Friday, October 4th. Finally, Deutsche Bank Aktiengesellschaft reduced their target price on shares of Humana from $349.00 to $250.00 and set a “hold” rating on the stock in a report on Thursday, October 3rd. Twenty analysts have rated the stock with a hold rating and six have issued a buy rating to the stock. Based on data from MarketBeat, the company has a consensus rating of “Hold” and a consensus price target of $315.86.

Humana Stock Down 1.1 %

HUM stock opened at $293.09 on Tuesday. Humana has a 12-month low of $213.31 and a 12-month high of $502.73. The company has a market cap of $35.29 billion, a price-to-earnings ratio of 25.96, a PEG ratio of 2.34 and a beta of 0.53. The company has a 50 day moving average of $275.33 and a two-hundred day moving average of $329.24. The company has a quick ratio of 1.76, a current ratio of 1.76 and a debt-to-equity ratio of 0.67.

Humana (NYSE:HUM) last released its quarterly earnings results on Wednesday, October 30th. The insurance provider reported $4.16 earnings per share for the quarter, topping the consensus estimate of $3.48 by $0.68. Humana had a net margin of 1.18% and a return on equity of 13.20%. The firm had revenue of $29.30 billion during the quarter, compared to the consensus estimate of $28.66 billion. On average, equities analysts anticipate that Humana will post 15.86 earnings per share for the current fiscal year.

Humana Announces Dividend

The company also recently announced a quarterly dividend, which will be paid on Friday, January 31st. Stockholders of record on Tuesday, December 31st will be given a $0.885 dividend. This represents a $3.54 annualized dividend and a dividend yield of 1.21%. The ex-dividend date is Tuesday, December 31st. Humana’s dividend payout ratio (DPR) is currently 31.36%.

Humana Company Profile

Humana Inc, together with its subsidiaries, provides medical and specialty insurance products in the United States. It operates through two segments, Insurance and CenterWell. The company offers medical and supplemental benefit plans to individuals. It has a contract with Centers for Medicare and Medicaid Services to administer the Limited Income Newly Eligible Transition prescription drug plan program; and contracts with various states to provide Medicaid, dual eligible, and long-term support services benefits.